Syrs barchart
WebSyros Pharmaceuticals, Inc. (SYRS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 2.6500 +0.0900 (+3.52%) At close: 04:00PM EDT 2.7500 +0.10 (+3.77%) After hours: 07:05PM... WebFeb 11, 2014 · PPA-002235-8. 25 May 2012. 3.1 The System Requirements Specification ( SyRS ), specifies the requirements to be satisfied by a system, subsystem, Hardware Configuration Item (HWCI), component or other physical item, and optionally. the requirements for evidence that each requirement has been so satisfied.
Syrs barchart
Did you know?
WebSyros Pharmaceuticals (SYRS) Option Put/Call Volume, Put/Call Open Interest, and Put/Call Ratios to spot long and short option trends. ... Unique to Barchart.com, data tables contain an option that allows you to see more data for the symbol without leaving the page. Click the "+" icon in the first column (on the left) to view more data for the ... WebView the latest Syros Pharmaceuticals Inc. (SYRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. SYRS Syros Pharmaceuticals Inc. …
WebSYRS has a Quality Grade of C, ranking ahead of 31.76% of graded US stocks. SYRS's asset turnover comes in at 0.093 -- ranking 271st of 682 Pharmaceutical Products stocks. … WebApr 7, 2024 · Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. …
WebSYRS - Syros Pharmaceuticals Stock Interactive Chart - Barchart.com Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial or … WebJun 23, 2004 · Real-time Price Updates for Syros Pharmaceuticals (SYRS-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more
WebApr 6, 2024 · A high-level overview of Syros Pharmaceuticals, Inc. (SYRS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
WebAug 9, 2016 · One Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) insider upped their stake by 212% in the previous year. Simply Wall St. -7.73%. Dec-12-22 07:30AM. Syros Pharmaceuticals Announces Publication in Blood Advances Demonstrating the Potential of Tamibarotene in Patients with RARA Gene Overexpression, Supporting Ongoing Clinical … home health charting systemWebApr 4, 2024 · SYRS Price $2.67 Fair Value Price $39.09 Market Cap $54.20M 52 Week Low $2.58 52 Week High $13.19 P/E -0.36x P/B 0.42x P/S 3.05x PEG N/A Dividend Yield N/A Revenue $14.88M Earnings -$94.65M Gross Margin 100% Operating Margin -608.33% Profit Margin -636.1% Debt to Equity 0.91 Operating Cash Flow -$123M Beta 1.2 Next Earnings … hilton york postcodeWebApr 12, 2024 · Syros Pharmaceuticals - SYRS Institutional Ownership $2.56 -0.11 (-4.12%) (As of 04/3/2024 12:00 AM ET) Compare Today's Range $2.54 $2.67 50-Day Range $2.56 $5.32 52-Week Range $2.54 $13.19 Volume 125,637 shs Average Volume 132,312 shs Market Capitalization $51.97 million P/E Ratio N/A Dividend Yield N/A Price Target $16.00 … hilton york hotel yorkWebApr 7, 2024 · Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is mainly involved in the... hilton york tower street parkingWebMarket data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. home health chart audit formWebSep 15, 2024 · TYME Technologies, Inc. CAMBRIDGE, Mass. and BEDMINSTER, N.J., Sept. 15, 2024 (GLOBE NEWSWIRE) -- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control ... home health charting programsWebPrices were available within the past 7 days and start at $76 for one-way flights and $152 for round trip, for the period specified. Prices and availability are subject to change. … home health chart review tool